Skip to main content

Table 3 Secondary outcomes

From: Dexmedetomidine improved renal function in patients with severe sepsis: an exploratory analysis of a randomized controlled trial

Data field

DEX group

(n = 54)

Non-DEX group

(n = 50)

P value

Renal replacement therapy in ICU, n (%)

27 (50)

29 (58)

0.41

Ventilator-free days, d, median (IQR)

18 (0, 23)

5 (0, 20)

0.09

28-day mortality, n (%)

12 (22)

21 (42)

0.03

Hospital mortality, n (%)

15 (28)

26 (52)

0.01

  1. DEX dexmedetomidine, ICU intensive care unit, IQR interquartile range
  2. We showed p<0.05 in italic font.